# The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region

> **NCT06561529** · NA · RECRUITING · sponsor: **MDCECRO LLC** · enrollment: 10 (estimated)

## Conditions studied

- Fibrosis
- Liver

## Interventions

- **DEVICE:** Gastric Bypass Stent System

## Key facts

- **NCT ID:** NCT06561529
- **Lead sponsor:** MDCECRO LLC
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-13
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06561529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06561529, "The Gastric Bypass Stent System as a Treatment for Hepatic Fibrosis in Obese Patients in European Region". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06561529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*